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Most forms of bodily injury are associated with a  marked increase in pro- 
teolytic activity. It has been suggested that during conditions of tissue damage 
(1) and systemic shock (2) activation of proteolytic mechanisms results in the 
formation of vasoactive products which are responsible for many of the mani- 
festations of injury. Attempts have been made (3, 4)  to establish the impor- 
tance of particular proteolytic factors by treating animals with chemical in- 
hibitors which under in vitro conditions act on particular proteolytic systems. 
Most of these experiments have provided suggestive but inconclusive informa- 
tion,  primarily because of the unknown  biological activity of the  inhibitors 
employed.  An  important  recent  advance  has  been  the  demonstration  that 
competitive snbstrates  can be used to inhibit particular proteolyfic enzymes 
or the endogenous activators of these systems (5). 
The present study is concerned with the application of such inhibitors as a means 
of elucidating  the chemical mechanisms concerned with a number of different injury 
phenomena.  Included in the group of inhibitors tested for a protective action, are 
soybean trypsin inhibitors  (6),  tosylarginine  methyl ester  (5),  and  epsilon  amino- 
caproic acid (lysine with the alpha amino group deleted)  (7)--all of which are general 
inhibitors of the tryptic type of proteolytic enzymes.  Studies with enzymes of the 
trypsin class have shown that they are activated from their inactive precursors by 
splitting off one of the basic  amino acids,  arginine  or lysine (5). The activators of 
plasmin  appear  to  be more closely associated  with lysine  substrates (8). These in- 
hibitors were studied, not because of our conviction that these particular enzymes are 
involved, but rather because the chemical basis of their action has been worked out. 
We were primarily concemed with two facets of the problem--the possible involve- 
ment of proteolytic enzymes in the disruptive hemorrhage developing during severe 
injury to the skin, and the relation of the increased proteolytic activity of the blood 
to the systemic toxemia following lethal trauma or stress. In addition, an attempt was 
made by such treatment to circumvent the lethal manifestations  of acutely lethal 
endotoxemia and anaphylaxis. 
* Supported by grants from the United States Public Health Service (FI-2267) and the 
American Heart Association. 
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The  effect  of agents on  the  inflammatory process  has  been difficult to  evaluate 
because of the subjective nature of the end-point. The local accumulation of a  blue 
dye complexed to plasma albumin (9)  does not represent an adequate expression of 
the overlapping series of changes which develop during tissue injury. We therefore 
employed  several  forms  of  tissue  damage  which  lend  themselves  to  more  definite 
evaluation by virtue of the fact that they terminate in local hemorrhage and necrosis. 
Included in this category are the lesions produced by bacterial endotoxins (10,  11) 
and antigen-antibody interactions (12). 
The  present  paper  demonstrates  that  animals  treated  with  competitive 
inhibitors of  proteolysis  were  protected  against  the  development  of  several 
different types of injury; rabbits were resistant to several forms of local hemor- 
rhagic necrosis; mice survived normally lethal anaphylaxis; and rats and mice 
withstood better acutely lethal doses of bacterial endotoxin. 
Materials and Methods 
Tissue injury was studied in the rabbit (1.7 to 2.0 kg.  body weight),  using a  number of 
different experimental models. A dermal Shwartzman reaction was produced by injecting 100 
vg. of an Escherichia cdi endotoxin intracutaneousiy (13) and  subsequently at  18 hours a 
similar amount of endotoxin intravenously. The  second  model was  a  modification of the 
Shwartzman lesion, as described by Thomas (11). Skin sites were prepared by injecting  0.2 ml. 
containing 100 ug. epinephrine intracutaneously  and giving 100 ~g. of endotoxin concurrently, 
either by an intravenous route, or by combining the bacterial extract with the epinephrine. 
Such areas develop a typical erythema, edema, and hemorrhagic necrosis within 4 to 6 hours. 
In view of reports in the literature linking the local manifestations of antigen-antibody 
interaction to activation of proteolytic enzymes (14),  the Arthus reaction was studied in 
rabbits. A reverse  Arthns reaction was induced by injecting rabbit antibody to ovalbumin 
into the skin and shortly thereafter injecting the antigen intravenously. Such reactions de- 
velop rapidly and within 3 to 5 hours are hemorrhagic and edematous. 
Anaphylaxis was studied in the mouse and guinea pig. Male and female mice of the Swiss- 
Webster strain, weighing between 20 and 30 gin. were used. They were injected intravenously 
with 0.5 ml. of a solution of solubilized antigen-antibody complexes  (rabbit antiovalbumin) 
which contained a  total of 1.5 mg. of antibody protein. The complexes were  prepared  I by 
adding antigen to known amounts of antibody, centrifuging down the precipitate, washing 
the precipitate and then redissolving it in 20 X  antigen excess. The resulting complex, when 
injected into control mice, was 60 per cent lethal within 6 hours. 
In the guinea pig,  rabbit antibody to crystalline ovalbumin was injected intravenously 
and within a  few  minutes the antigen (ovalbumin) was given intravenously. Anaphylaxis 
developed  within a few minutes and the doses were so adjusted as to provide LDs0 to LDe0 
value. 
Passive cutaneous anaphylaxis was studied in the guinea pig according to the method of 
Ovary (15). In brief, six separate skin sites were sensitized  by the injection of 0.1 ml. of a 
solution containing 0.02 #g. of  rabbit anti-ovalbumin antibody N  per ml. After a  3 hour 
latent period,  the animal received intravenously 70/zg. of ovalbumin protein (2 times crystal- 
lized, Worthington Chemical Co.)  together with 0.25 ml. of a  t  per cent solution of Evans 
blue dye to demarcate the resulting injury. 
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The systemic effects of bacterial  endotoxin  were studied  in  two  ways.  Acutely  lethal 
amounts of extracts  of E. coli or Salmonella enteritidis were given intraperitoneally  to mice, 
rats, and rabbits. 
Two suitably  spaced injections  of bacterial  endotoxins produce  a  systemic  reaction  in 
rabbits,  the generalized Shwartzman reaction, which has been reported  to be accompanied 
by changes in the proteolytic activity of the blood (16). The Shwartzman reaction was induced 
by an intravenous injection  of 100 #g. E. ¢oli lipopolysaccharide and 18 to 24 hours later by 
a second injection of a similar amount of bacterial  extract.  The  animals were sacrificed 24 
hours later and the kidneys then examined for evidence of bilateral  cortical necrosis and fibri- 
noid deposits. 
Traumatic shock was induced by rotation of rats in the Noble-CoUip dram (17). The E. 
¢oli and Salmonella typhosa endotoxins were prepared  by Dffco Company according to the 
method of Landy and Johnson described in reference 18. The soybean trypsin inhibitor was 
prepared by Worthington  Chemical Co., and epsilon aminocaproic acid (EACA)  2 by Aldrich 
Chemical Company. Tosylarginine methyl ester (TAME) s was synthesized in the laboratory. 
RESULTS 
I.  Dermal Reaction Produced by Mixtures of Epinephri~ and 
Bacterial Endotoxin 
For  purposes  of  orientation,  our  initial  experiments  were  confined  to  the 
dermal  reactions  produced  by mixtures  of  100  #g.  epinephrine  and  100  gg. 
bacterial  endotoxin.  This  combination  produces  hemorrhagic  necrosis  in  the 
skin of rabbits with a  high degree of reproducibility  (85 to 90 per cent). 
1.  Soybean Trypsin Inhibitor (SBTI)*.-- 
Soybean  trypsin  inhibitor  has  been  reported  to  suppress  inflammatory 
reactions  (18).  SBTI was injected intravenously into rabbits  in doses ranging 
from 5  to 30 mg./kg,  and at time intervals ranging from 2 to 3  hours before 
to 3 to 5 hours after the dermal challenge. 
A  positive  inhibitory  effect  was  obtained  only when  the  SBTI  was  given 
just prior to dermal injection, and in amounts of at least  25 to 30 mg./kg. As 
shown in Table I, animals  which received 30 rag.  of SBTI 15 minutes before 
the dermal injection,  showed a  significant reduction in both the severity and 
incidence  of  hemorrhagic  necrosis  (38  per  cent,  only  10/24  positive).  The 
majority of skin  sites  became edematous but  within  3  hours had reverted  to 
an almost normal appearance. 
In another group of six rabbits,  the inhibitor was added to the epinephrine- 
endotoxin  vehicle  and  injected  locally.  Here  only a  modest  decrease  in  the 
number  of  hemorrhagic  and  necrotic  sites  was  encountered  (10/18  experi- 
mental,  as compared with 10/12 controls). 
It was found that  maximal protection  was afforded in instances  when  the 
2 EACA, epsilon aminocaproic acid. 
s TAME, tosylarginine methyl ester. 
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inhibitor was  given intravenously from 5  to  10 minutes before injecting the 
skin sites. No effect on the reaction was observed when the inhibitor was given 
as late as 30 minutes after the epinephrine mixture had been injected into the 
skin. 
2.  Tosylarginine Methyl Ester (TAME).-- 
In order to rule out non-specific properties of the soybean extracts and to 
delineate further the system involved, two synthetic inhibitors were studied. 
The fact that it had been necessary to inject the SBTI in advance of the damag- 
ing agent  suggested  that  a  rapidly activated process was  involved.  TAME 
has been found (5, 6) to have a more prompt inhibitory effect than SBTI on 
proteolytic systems under in vitro conditions. It was therefore anticipated, if 
TABLE I 
Effect of SBTI on Dermal Reaction in Rabbit Induced  by Mixtures of Endotoxin  and 
Epinephrine 
Time of administration  relative  to chaUenge*  SBTI dose:[:  Positive lesions 
15 min. before 
60 min. before 
Mixed with endotoxin 






8/8  (100%) 
14/16  (88%) 
10/12  (83%) 
10/24  (38%) 
5/8  (82%) 
lO/18  (55%) 
14/18  (77%) 
* 100 #g. epinephrine  +  100 ~g E. coli endotoxin i.d. in 0.2 ml. 
:~ per 1.7 to 2.0 kg. rabbit. 
an autocatalytic reaction was involved, that TAME should be more effective 
than SBTI in counteracting the reaction to injury. 
TAME in doses of 15 to 20 mg./kg, dearly suppressed the development of 
hemorrhagic lesions following mixtures of epinephrine and endotoxin (100 #g. 
of each). As indicated in Table II, optimal protection was achieved in animals 
which received TAME for 2 successive days together with a  booster dose of 
20 mg. just before the intradermal test injection. 
A major premise in these experiments is the assumption that  these agents 
are in fact acting as inhibitors of proteolysis. This thesis was put to test by 
using  tosylarginine  (TA),  6 the  product  of proteolytic action  upon  TAME, 
which,  although  chemically similar,  does  not  act  as  a  proteolytic inhibitor. 
Tosylarginine in  comparable amounts  (10  to  25  nag.)  had  no  effect on  the 
dermal  reaction to  injury  (9/10 positive lesions  with  epinephrine-endotoxin 
mixtures). 
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3.  gpsilon Aminocaproic Acid (EACA).-- 
Inspection of the various combinations in  our biological test  system sug- 
gested that a  two-step phenomenon might be involved in the development of 
the  injury reaction following epinephrine and  endotoxin.  Since TAME  was 
more effective when given during the initial period of the skin preparation, it 
seemed plausible to assume that the inhibitor might be acting by interfering 
TABLE II 
Effect of TAME  on Dermal Reaction in the Rabbit Induced  by Mixtures of Endotoxin  and 
Epinephrin~ 
Dose* (rag.)  No. o| injections  Positive lesions~; 
15 (i.v.)  3§  17/20 (8.5%) 
20 (i.v.)  1  8/20  (40%) 
20 (i.d.)  1, locally  16/20 (80%) 
* per 1.7-2.0  kg. rabbit. 
:~ Mixture of 100 #g. E. c.oli  endotoxin  and i00 ~g. epinephrine, 0.2 ml. i.d. 
§ 12 hours apart, hst just prior to skin challenge. 
TABLE III 
Effect of EACA  on Dermal Reaction in the Rabbit Induced  by Mixtures of Endotoxin and 
Epinephrine 












4/14  (28%) 
3/6  (50%) 
1/8  (12%) 
4/14  (28%) 
11/12 (91%) 
20/24 (63%) 
* per 1.7 to 2.0 kg. rabbit. 
at 24-hour intervals, last just prior to skin challenge. 
§ Mixture of 100 ~g. E. coil endotoxin and 100 ~g. epinephrine,  0.2 ml., i.d. 
with an activator mechanism. Inasmuch as activators of this type are usually 
present only in small amounts, once the process starts and a  substantial con- 
centration of the proteolytic enzyme is produced, a substance such as TAME 
would be rapidly hydrolyzed to TA and no longer effective. Comparatively 
high doses of TAME would therefore be required to interfere with proteolysis 
per $~. 
Recently, it has been reported (19)  that it is possible to interfere with the 
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with  EACA.  This  substance  is  also more effective  than  TAME  in inhibiting 
the initial  phase of the reaction as opposed to the proteolytic step per se. 
EACA, in intravenous doses ranging from 500 ~g. to 10 mg./kg,  was found 
to be effective in the rabbit in counteracting the hemorrhagic lesions produced 
by mixtures of epinephrine and endotoxin (Table III). There was no apparent 
correlation  between  the  dose used  and  the  degree of protection  afforded.  On 
the other hand,  addition of EACA (0.1  to 1.0 mg.)  directly onto the skin site 
not only was ineffective,  but  increased  the  resulting  area  of hemorrhage  and 
necrosis. 
TABLE IV 
Effect  of Proteolytio  Inhibitors  on  Various  Forms  of Injury 


















I00 ug. E. coli endotoxin (i.v.) + 
100 ug. E. coli (i.v.) 
Ovalbumin,  rabbit  anti-ovalbu- 
rain 
Ovalbumin,  rabbit  anti-ovalbu- 
min 
2 doses of I00 #g.  E.  coli endo- 
toxin (i.v.) 18 hours apart 
2000 #g. E. coli endotoxin (i.v.) 
250 ug. E. coli endotoxin (i.v.) 
200 ug. E. coli endotoxin (i.v.) 
Positive reactions 
Controls  EACA* FAME  * 
12/141  6/10  8/12 
8/8  13/16  3/4 
13/16  21/27  7/7 
8/10  9/12  9/12 
9/12  6/10  9/10 
8/12  8/10  9/10 
10/12  6/10  6/10 
* EACA, 30 rag. (i.v.), TAME, 25 rag.  (i.v.), for 48 hours preceding challenge and just 
prior to test dose, except when noted otherwise in the text. 
:~ Rats weighed between 120 and 175 gin.; rabbits between 1.7 and 2.0 kg.; mice between 
20 and 30 gin. 
4.  Other Forms of Injury.- 
We then  turned  our attention  to  several  other forms of tissue  damage,  in- 
cluding  the classic dermal  Shwartzman  phenomenon,  and  the passive  Arthus 
reaction in the rabbit.  As indicated in Table IV,  neither of these two phenom- 
ena was modified by the administration  of either TAME or EACA. 
The generalized Shwartzman phenomenon was produced in two groups of rabbits  (12 in 
each), one of which received TAME (25 mg./kg.)  and the other EACA (30 mg./kg.)  as indi- 
cated in Table IV. In these instances the inhibitors were given intravenously for 2 days prior 
to the priming dose of E. ¢oli endotoxin,  at hourly intervals  for 6 hours thereafter,  and in 
conjunction with the provoking dose of endotoxin. 
There was no evidence,  either gross or microscopic, of a  diminished  deposi- 
tion  of fibrinoid  material  in  the  blood vessels,  or  of  a  lessened  incidence  of 
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Single large doses of bacterial endotoxin are rapidly lethal in most labora- 
tory animals, causing prostration and death within 4  to 12 hours.  In view of 
known species differences in the reaction to bacterial extracts, endotoxic shock 
was studied in the rat, rabbit, and mouse. 
In each case  (see Table IV), the animals received an amount of endotoxin 
designed to produce an LD60 to LD75 in controls. Both TAME and EACA were 
used. The two inhibitors were given both before and for several hours after the 
endotoxin.  The rats and mice looked manifestly better,  showing no diarrhea, 
ruffling of the hair, and did not have the usual tendency to huddle in the corner 
of the cage. All of the animals survived for at least 9 to 10 hours and the only 
deaths occurred overnight. Mortality  figures  were  more favorable in  the  rat 
and mouse than in the rabbit (Table IV). 
TABLE V 














* 700 turns in Noble-Collip  drum. 
J; per 1.7 to 2.0 kg. rabbit. 
Passive cutaneous anaphylaxis was produced in the skin of 18 guinea pigs. 
Eight animals were pretreated with 30 rag. EACA intravenously at 20 hours 
before and again 1 hour before the challenge. Four animals received 30 rag. of 
TAME  (intravenously)  just before  the  PCA  6 tests.  In  no  case  (Table  IV) 
was the size or intensity of the tissue damage diminished appreciably.  ~ 
The influence of EACA and TAME on traumatic shock was studied in the 
rat following rotations in the Noble-Collip drum. Here again, as in endotoxic 
shock, both of the inhibitors  gave significant protection against the lethality 
of drum trauma (Table V). The animals appeared less cyanotic and much more 
alert  when  removed from the  drum.  Deaths  were  associated with  extensive 
hemorrhage into the intestinal tract and congestion and swelling of the liver. 
5.  Systemic AnaphyIaxis.-- 
Mice, which received 0.5 ml. of the solubilized antibody-antigen complex (see Material and 
Methods), were divided into two groups: one was given 30 rag. EACA in saline (intraperi- 
toneally) and the other an equivalent volume of saline alone (intraperitoneally). 
6 PCA, passive cutaneous anaphylaxis. 
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The data in Table VI indicate that animals receiving EACA showed a  high 
degree of protection, particularly when the material  was  administered some 
8 to 14 hours previous to the anaphylaxis. Untreated mice died within 2 to 4 
hours.  The  majority  of  the  treated  mice  showed  only minor  symptoms,-- 
diarrhea, apprehension, but no cyanosis, respiratory embarrassment, or shock. 
Comparable studies were carried out in the guinea pig, using an ovalbumin- 
rabbit  anti-ovalbumin  anaphylaxis.  However,  in  a  series  of 36  guinea  pigs 
(250 to 300 gm.) treated with EACA  (see Table VI)--either in the form of a 
single injection just prior to the challenge, or several injections for 24 hours 
prior to the shock--only slight protection was demonstrated against the lethal 
course of the reaction. 
TABLE  VI 
Effea of EACA  on  Acutely  Lethal Anaphylaxis* 
Controls  Treated 
Mouse  15/20  6/21 :~ 
20/22  14/22 
Total ............  35/42 (83%)  20/43 (44%) 
Guinea pig  12/12  9/12§ 
10/12  9/12 
11/12  10/12 
Total ..............  33/36 (89%)  28/36 (77%) 
* i.v. injection solubilized antigen-antibody complex (as indicated in text). 
:~ 30 mg. EACA i.p., 8 hours prior to anaphylactic challenge. 
§ 25 rag./100 gin. body weight. 
6.  General Effects of TA ME and EA CA.-- 
It  was  necessary to  establish  whether EACA  and  TAME  acted  on  other 
biological mechanisms, some of which are known to alter the susceptibility to 
tissue damage and to shock. 
A.  Pharmacological properties: The  two  inhibitors  were found  to have  no 
effect on the mean blood pressure as recorded by mercury manometer in rats, 
rabbits, or guinea pigs (6 each) anesthetized with pentobarbital (30 mg./kg.). 
Tests were also conducted on the pressor or depressor action of intravenously 
administered  vasoactive  agents,--epinephrine,  norepinephrine,  acetylcholine 
(mecholyl), histamine,  and  5-hydroxytryptamine. In  no  case  did  treatment 
with  these  inhibitors  interfere with  the  intensity or  duration  of  the  blood 
pressure changes with the above drugs. 
Measurements of coagulation time were carried out in a series of 12 rats and 
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into No. 60 polyethylene catheter tubing (method of Spaet, 20). Only a minor 
decrease in coagulation time was observed transiently in animals  which had 
received high doses of TAME  (30 mg./kg.) and EACA (40 mg./kg.).  On the 
other hand,  a  definite effect was noted on the disturbed coagulability of the 
blood which is induced by systemic endotoxin. 
In untreated animals, endotoxin (50 to 100 #g., intravenously administered) 
caused a biphasic change--an initial short lived period (15 to 20 minutes)  of 
hypercoagulability followed by a  more protracted (45 to 120 minutes)  hypo- 
coagulable phase. Rats and rabbits pretreated with 30 mg. EACA/kg. showed 
an attenuation of both the hyper- and hypocoagulable phase following lethal 
amounts of endotoxin. 
Blood counts (WBC, RBC, and platelets) revealed no significant  change in 
either the number or distribution of cells. 
The status of the reticulo-endothelial system (RES) has been shown to be 
an important  factor in the systemic response to various forms of stress and 
endotoxemia  (21-25).  In  the  current  studies,  measurements  were  therefore 
made of the efficiency of the RES by the rate of clearance of colloidal material 
from the blood stream, using the method of Biozzi, Benacerraf, and Halpem 
(26). Neither TAME nor EACA had any significant  effect on the phagocytic 
index measured from 1 to 4 hours after the administration of these agents in a 
group of 6 rats and 6 rabbits. 
B.  Local inflammatory  reaction: The fact that  the severity of tissue injury 
is related to the availability and release  of vasoactive amines within the af- 
fected site led us to determine whether or not the inhibitors under investigation 
acted to deplete tissue stores of these amines.  For this purpose, xylene was 
used to produce a local inflammatory reaction and the magnitude of the effect 
measured by the rate of appearance and intensity of the local blueing reaction 
in the region (9). 
The skin of three rats and three rabbits was shaved and several sites in each 
were painted with xylene and Evans blue (0.5 ml.  of a  1 per cent solution) 
injected intravenously. The development of the exudative blueing reaction was 
essentially similar  in controls and in animals  treated,  as previously, with 30 
rag. of EACA or 35 rag. of TAME. 
DISCUSSION 
Several basic  questions must  be answered in  any  discussion  of the  data. 
First, are the materials used acting under in vivo conditions to inhibit proteo- 
lysis? Secondly,  is the protective action in a particular form of injury related 
to this inhibitory action? Thirdly, are the observed effects due to an indirect 
action unrelated to proteolytic phenomena? 
The fact that each of three different inhibitors, EACA, TAME, and SBTI, 
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systemic stress is highly suggestive evidence that proteolytic mechanisms are 
in fact important determinants of such reactions. Although these  substances 
are  known under in  vitro  conditions to  inhibit enzymes of the  trypsinogen- 
trypsin and plasminogen-plasmin class  (7, 8),  the animal experiments cannot 
be used by themselves to implicate a particular enzyme system in the response 
to tissue injury (27). 
Reports in the literature make it obvious that the manifestations of tissue 
injury are mediated by several separate pathways. The data provided by the 
present study delineate one of these pathways. Inasmuch as several basically 
different forms of tissue damage are affected by EACA and TAME, it is prob- 
able  that  a  common mechanism exists through which most forms of injury 
pass before diverging into a series of end-reactions. 
Several  ancillary observations further strengthen  our contention that  the 
protective action of EACA or TAME in our experiments is related to their 
effect on  activation of proteolysis.  Neither  of  these  drugs  has  any demon- 
strable musculotropic or vasotropic action on the blood vessels.  In addition, 
tosylarginine, a  chemically similar  substance  without proteolytic inhibitory 
properties, has no effect on the course of tissue injury. 
In view of species differences and conditions peculiar to particular forms of 
injury or systemic stress, it is obvious that generalizations in this regard are 
not warranted. This is clearly indicated by our finding that EACA prevents 
the lethal consequences of systemic anaphylaxis in the mouse but not appre- 
ciably in  the  guinea pig.  Inasmuch as  antihistaminics are  effective against 
anaphylaxis in both species  (28-30),  it is probable that different pathways are 
involved in the release of the mediators responsible for the toxic reaction. 
The  majority of experiments in  the  present  series  were  carried  out  with 
epsilon  aminocaproic  acid  (EACA)  because  of its  superior  properties  as  an 
inhibitor of proteolytic activation under in vitro conditions, and because it was 
found to be well tolerated in contrast to the toxicity of soybean trypsin inhibi- 
tor (SBTI) and tosylarginine methyl ester (TAME) in optimal effective con- 
centrations.  EACA,  thus,  was  able  to  provide a  more favorable test  of the 
relative importance of proteolytic factors in the genesis of tissue injury. 
With respect  to  the  mechanisms of action,  it  should  be  noted that  both 
TAME  and  EACA were  especially effective against tissue lesions which in- 
volved epinephrine as an initiating factor. A  similar relationship would seem 
to be indicated by the protective action of these two inhibitors against the 
lethal and toxic manifestations of systemic shock and endotoxemia,--conditions 
in which the release of vasoactive amines is prominently involved (31). 
The data offer some insight into the biochemical processes which may be 
involved in  the  reaction  to  injury.  Many of  the  published  reports  (32-35) 
emphasize the formation through proteolytic activity of vasoactive polypep- 
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responsible for the vascular dilation and capillary damage encountered in all 
forms of injury. In this regard,  EACA or TAME may act, as they do under 
in vitro conditions  (34), to inhibit  the formation of these polypeptides. Other 
workers have emphasized the formation and release  of histamine  or H  sub- 
stance during injury (36). Neither TAME nor EACA has a direct antihistaminic 
action. It has been reported (37) that epinephrine causes the release  of plas- 
minogen  activator.  It  should  be  emphasized  that  the  role  of  plasminogen 
activator  may be much  wider  than  that  implied  by its known  function in 
regard to the specific enzyme plasmlnogen.  Furthermore, epinephrine has been 
shown  to  activate  other  enzymatic  systems,  including  thromboplastin  and 
trypsin (37). 
The observation that epinephrine-activated lesions were inhibited by EACA, 
whereas neither the classical local Shwartzman nor the Arthus reactions were 
affected, suggests a  basic difference  between the  two phenomena.  Both the 
Arthus and the dermal Shwartzman reactions involve a period of preparation 
characterized by heavy infiltration of the tissue with leucocytes which subse- 
quently degenerate  and  fragment  coincident with the onset of local hemor- 
rhage  (38).  The  destruction  of these cells  undoubtedly liberates proteolytic 
enzymes in an already active form. EACA is not an effective inhibitor of the 
proteolytic enzymes themselves,  although  it  does prevent  the  activation  of 
such enzymes from their precursors. 
Miles and Wilhelm  (39) have reported that soybean trypsin inhibitor dimin- 
ishes the local increase in permeability following several forms of tissue damage. 
SBTI is known to interfere with the activation of thrombin and plasminogen. 
In the current studies, the inflammatory response of the skin to xylene or to 
bacterial extracts was not affected by EACA or TAME. On the other hand, 
those lesions,  which subsequently progressed to the point at which vascular 
disruption, hemorrhage,  and necrosis appeared, were clearly interrupted before 
this phase of the reaction developed. The two aspects of the phenomenon may 
therefore involve different enzyme systems. 
SUMMARY  AND  CONCLUSIONS 
A study was made of the development of various forms of local and systemic 
injury in animals  treated  with inhibitors  of proteolytic activity. The agents 
used  were  tosylarginine  methyl  ester  (TAME),  epsilon  aminocaproic  acid 
(EACA), and soybean trypsin inhibitor (SBTI). 
1.  Hemorrhagic  necrosis  in  the  skin  of  the  rabbit  following  intradermal 
epinephrine  in  combination  with  bacterial  endotoxin  (either  intravenous  or 
local) was clearly suppressed by EACA, TAME, and SBTI, given systemically. 
Tosylarginine (TA) was ineffective. 
2.  No effect was observed on the classical  Shwartzman  reaction,  the local 
Arthus phenomenon, or inflammation induced by xylene. 448  PROTEOLYTIC INHIBITORS IN INJURY 
3.  The  lethal  effects of  systemic  anaphylaxis  in  the  mouse,  acute  endo- 
toxemia in the rat and mouse, and drum shock in  the rat are suppressed by 
EACA and TAME. 
4.  There was no effect on the generalized Shwartzman phenomenon in the 
rabbit and on anaphylaxis in the guinea pig. 
5.  The effects of EACA or TAME on the injury reactions under investigation 
were not  due to a  pharmacological or chemical action on vascular behavior 
per $6. 
6.  The data provide corroborative evidence for a  proteolytic step in injury 
phenomena which may be mediated through some common activation system. 
7.  The working hypothesis is advanced that local or systemic stress through 
the release of epinephrine may result in an increase of a  circulating activator 
of proteolysis and that this in turn may give rise to the release of vasoactive 
substances,--possibly histamine, serotonin, or a polypeptide. 
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